Policy Cures

G-FINDER report: Governments cutting funding for neglected disease R&D

Friday, December 13, 2013

The sixth annual G-FINDER survey reported both good and bad news on global investment into R&D for new neglected disease products. The good news is that global funding for neglected disease R&D totaled $3.2 billion in 2012, thanks to an increase in funding from repeat survey participants of $92.1 million (up 3.2%) over 2011 levels—a positive change as global investment in neglected disease R&D had been declining since 2009. But in 2012, non-U.S. government funding fell by $52.6 million (down 12.4%), with 11 governments cutting or freezing funding. Since the global financial crisis, total investment from this group has fallen by 20% ($90.6 million).

[Read More]